Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company focused on discovering and developing RNA-targeted therapeutics. It generates revenue through licensing agreements, partnerships with other pharmaceutical companies, and sales of its proprietary drug therapies.
The ten most recent trades of Ionis Pharmaceuticals in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
---|---|---|---|---|
Dec 18, 2024 | Sell | $2,150,716 | 5.39% | 0.18% |
Dec 17, 2024 | Sell | $909,554 | 2.18% | 0.08% |
Dec 16, 2024 | Sell | $712,695 | 1.68% | 0.06% |
Dec 13, 2024 | Sell | $970,102 | 2.28% | 0.08% |
Aug 09, 2024 | Buy | $612,001 | 1.14% | 0.05% |
Aug 08, 2024 | Buy | $60,913 | 0.11% | 0.00% |
Aug 07, 2024 | Buy | $103,241 | 0.19% | 0.01% |
Aug 05, 2024 | Buy | $1,006,054 | 1.91% | 0.08% |
Feb 16, 2024 | Sell | $713,504 | 1.04% | 0.04% |
Jan 23, 2024 | Sell | $255,504 | 0.32% | 0.01% |